Surgical experience with implantable insulin pumps

Jon S Thompson, William C. Duckworth, Christopher D. Saudek, Anita Giobbie-Hurder

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

BACKGROUND: A recent Veterans Affairs cooperative trial demonstrated that intensive insulin therapy via an implantable pump with intraperitoneal insulin delivery reduced glycemic variability and improved quality of life compared with multiple daily insulin injections. Our aim was to determine perioperative morbidity and assess long-term function of the implantable insulin pump. METHODS: Fifty-one adult patients with type 2 diabetes had infusion pumps placed over a 2-year period at seven VA Medical Centers as part of a randomized prospective study. RESULTS: All pumps were placed successfully. There were two (4%) perioperative complications. There were no wound complications. Duration of pump use ranged from 12 to 25 months (mean 20). Catheter obstruction (57%) and pump malfunction (25%) were the most common reasons for pump explantation. Catheter occlusions increased after 12 months. Catheter occlusion was treated by percutaneous rinse procedure in 75% and revisional procedures in 31% of patients. CONCLUSIONS: Implantable insulin pumps can be placed with minimal surgical morbidity. Attention to surgical detail and infusion protocol permits satisfactory long-term function. Pump/catheter complications increase with time but are usually resolvable by either operative or percutaneous manipulations.

Original languageEnglish (US)
Pages (from-to)622-626
Number of pages5
JournalAmerican journal of surgery
Volume176
Issue number6
DOIs
StatePublished - Jan 1 1998

Fingerprint

Insulin
Catheters
Catheter Obstruction
Morbidity
Infusion Pumps
Veterans
Type 2 Diabetes Mellitus
Quality of Life
Prospective Studies
Injections
Wounds and Injuries
Therapeutics

ASJC Scopus subject areas

  • Surgery

Cite this

Surgical experience with implantable insulin pumps. / Thompson, Jon S; Duckworth, William C.; Saudek, Christopher D.; Giobbie-Hurder, Anita.

In: American journal of surgery, Vol. 176, No. 6, 01.01.1998, p. 622-626.

Research output: Contribution to journalArticle

Thompson, JS, Duckworth, WC, Saudek, CD & Giobbie-Hurder, A 1998, 'Surgical experience with implantable insulin pumps', American journal of surgery, vol. 176, no. 6, pp. 622-626. https://doi.org/10.1016/S0002-9610(98)00273-6
Thompson, Jon S ; Duckworth, William C. ; Saudek, Christopher D. ; Giobbie-Hurder, Anita. / Surgical experience with implantable insulin pumps. In: American journal of surgery. 1998 ; Vol. 176, No. 6. pp. 622-626.
@article{0e6cc09b098548718ccceaf9865b7ec8,
title = "Surgical experience with implantable insulin pumps",
abstract = "BACKGROUND: A recent Veterans Affairs cooperative trial demonstrated that intensive insulin therapy via an implantable pump with intraperitoneal insulin delivery reduced glycemic variability and improved quality of life compared with multiple daily insulin injections. Our aim was to determine perioperative morbidity and assess long-term function of the implantable insulin pump. METHODS: Fifty-one adult patients with type 2 diabetes had infusion pumps placed over a 2-year period at seven VA Medical Centers as part of a randomized prospective study. RESULTS: All pumps were placed successfully. There were two (4{\%}) perioperative complications. There were no wound complications. Duration of pump use ranged from 12 to 25 months (mean 20). Catheter obstruction (57{\%}) and pump malfunction (25{\%}) were the most common reasons for pump explantation. Catheter occlusions increased after 12 months. Catheter occlusion was treated by percutaneous rinse procedure in 75{\%} and revisional procedures in 31{\%} of patients. CONCLUSIONS: Implantable insulin pumps can be placed with minimal surgical morbidity. Attention to surgical detail and infusion protocol permits satisfactory long-term function. Pump/catheter complications increase with time but are usually resolvable by either operative or percutaneous manipulations.",
author = "Thompson, {Jon S} and Duckworth, {William C.} and Saudek, {Christopher D.} and Anita Giobbie-Hurder",
year = "1998",
month = "1",
day = "1",
doi = "10.1016/S0002-9610(98)00273-6",
language = "English (US)",
volume = "176",
pages = "622--626",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Surgical experience with implantable insulin pumps

AU - Thompson, Jon S

AU - Duckworth, William C.

AU - Saudek, Christopher D.

AU - Giobbie-Hurder, Anita

PY - 1998/1/1

Y1 - 1998/1/1

N2 - BACKGROUND: A recent Veterans Affairs cooperative trial demonstrated that intensive insulin therapy via an implantable pump with intraperitoneal insulin delivery reduced glycemic variability and improved quality of life compared with multiple daily insulin injections. Our aim was to determine perioperative morbidity and assess long-term function of the implantable insulin pump. METHODS: Fifty-one adult patients with type 2 diabetes had infusion pumps placed over a 2-year period at seven VA Medical Centers as part of a randomized prospective study. RESULTS: All pumps were placed successfully. There were two (4%) perioperative complications. There were no wound complications. Duration of pump use ranged from 12 to 25 months (mean 20). Catheter obstruction (57%) and pump malfunction (25%) were the most common reasons for pump explantation. Catheter occlusions increased after 12 months. Catheter occlusion was treated by percutaneous rinse procedure in 75% and revisional procedures in 31% of patients. CONCLUSIONS: Implantable insulin pumps can be placed with minimal surgical morbidity. Attention to surgical detail and infusion protocol permits satisfactory long-term function. Pump/catheter complications increase with time but are usually resolvable by either operative or percutaneous manipulations.

AB - BACKGROUND: A recent Veterans Affairs cooperative trial demonstrated that intensive insulin therapy via an implantable pump with intraperitoneal insulin delivery reduced glycemic variability and improved quality of life compared with multiple daily insulin injections. Our aim was to determine perioperative morbidity and assess long-term function of the implantable insulin pump. METHODS: Fifty-one adult patients with type 2 diabetes had infusion pumps placed over a 2-year period at seven VA Medical Centers as part of a randomized prospective study. RESULTS: All pumps were placed successfully. There were two (4%) perioperative complications. There were no wound complications. Duration of pump use ranged from 12 to 25 months (mean 20). Catheter obstruction (57%) and pump malfunction (25%) were the most common reasons for pump explantation. Catheter occlusions increased after 12 months. Catheter occlusion was treated by percutaneous rinse procedure in 75% and revisional procedures in 31% of patients. CONCLUSIONS: Implantable insulin pumps can be placed with minimal surgical morbidity. Attention to surgical detail and infusion protocol permits satisfactory long-term function. Pump/catheter complications increase with time but are usually resolvable by either operative or percutaneous manipulations.

UR - http://www.scopus.com/inward/record.url?scp=0032436616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032436616&partnerID=8YFLogxK

U2 - 10.1016/S0002-9610(98)00273-6

DO - 10.1016/S0002-9610(98)00273-6

M3 - Article

VL - 176

SP - 622

EP - 626

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

IS - 6

ER -